Susana Hernando

1.1k total citations
30 papers, 585 citations indexed

About

Susana Hernando is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Susana Hernando has authored 30 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Susana Hernando's work include Renal cell carcinoma treatment (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Herpesvirus Infections and Treatments (5 papers). Susana Hernando is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Herpesvirus Infections and Treatments (5 papers). Susana Hernando collaborates with scholars based in Spain, Netherlands and United States. Susana Hernando's co-authors include Jesús García-Donás, Cristina Rodríguez‐Antona, Mercedes Robledo, Luis J. Leandro‐García, H. Cortés-Funes, María Dolores Folgueira, Alicia Hurtado, Alberto Cascón, Cristina Montero‐Conde and Carlos Jara and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Susana Hernando

28 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susana Hernando Spain 13 215 169 145 132 88 30 585
Sudhir Singh India 12 97 0.5× 58 0.3× 153 1.1× 60 0.5× 48 0.5× 81 529
Troy J. Plumb United States 14 102 0.5× 62 0.4× 171 1.2× 108 0.8× 28 0.3× 36 802
Il Han Song South Korea 16 156 0.7× 354 2.1× 99 0.7× 113 0.9× 64 0.7× 54 791
Rong Yao China 13 79 0.4× 129 0.8× 224 1.5× 113 0.9× 108 1.2× 42 700
Çağ Çal Türkiye 14 108 0.5× 70 0.4× 108 0.7× 355 2.7× 50 0.6× 37 883
R.W. Stockbrügger Netherlands 19 124 0.6× 373 2.2× 134 0.9× 100 0.8× 35 0.4× 44 978
Paolo Malvezzi France 19 128 0.6× 219 1.3× 100 0.7× 89 0.7× 20 0.2× 93 1.1k
Thomas Shin United States 14 75 0.3× 275 1.6× 126 0.9× 33 0.3× 37 0.4× 38 742
Helene Skjøt‐Arkil Denmark 11 37 0.2× 138 0.8× 61 0.4× 83 0.6× 60 0.7× 51 512
Shipeng Yan China 14 72 0.3× 231 1.4× 96 0.7× 70 0.5× 61 0.7× 33 548

Countries citing papers authored by Susana Hernando

Since Specialization
Citations

This map shows the geographic impact of Susana Hernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Hernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Hernando more than expected).

Fields of papers citing papers by Susana Hernando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Hernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Hernando. The network helps show where Susana Hernando may publish in the future.

Co-authorship network of co-authors of Susana Hernando

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Hernando. A scholar is included among the top collaborators of Susana Hernando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Hernando. Susana Hernando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rogers, Heather, et al.. (2021). Barriers and facilitators in the implementation of an evidence-based health promotion intervention in a primary care setting: a qualitative study. Journal of Health Organization and Management. 35(9). 349–367. 31 indexed citations
3.
Santos, María, Javier Lanillos, Juan María Roldán‐Romero, et al.. (2021). Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma. Genetics in Medicine. 23(4). 698–704. 13 indexed citations
4.
Sotelo, Miguel J., et al.. (2017). P3.02c-100 Nivolumab beyond First-Line (1L) Treatment in Metastatic Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S1340–S1341.
5.
6.
7.
García-Donás, Jesús, Benoit Beuselinck, Lucía Inglada‐Pérez, et al.. (2016). Deep sequencing reveals microRNAs predictive of antiangiogenic drug response. JCI Insight. 1(10). e86051–e86051. 34 indexed citations
8.
Rico, Daniel, Ana Osório, Miguel Urioste, et al.. (2013). DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas. British Journal of Cancer. 108(8). 1732–1742. 11 indexed citations
9.
Bayo, Juan, Paula Jiménez Fonseca, Susana Hernando, et al.. (2012). Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles. Clinical & Translational Oncology. 14(6). 413–422. 31 indexed citations
10.
Hernando, Susana, et al.. (2012). Necesidades de información y uso de Internet en pacientes con cáncer de mama en España. Gaceta Sanitaria. 27(3). 241–247. 13 indexed citations
11.
Hernando, Susana, Jesús García-Donás, & Montserrat Climent. (2012). Phase II Study of Dovitinib in First Line Metastatic or (NON RESECTABLE PRIMARY) Adrenocortical Carcinoma (ACC). Sogug Study 2011-03. Annals of Oncology. 23. ix293–ix293. 2 indexed citations
12.
Salamanca, Javier, et al.. (2012). Esophageal verruciform xanthoma following radiotherapy. Gastroenterología y Hepatología. 35(5). 317–320. 8 indexed citations
13.
García-Donás, Jesús, Susana Hernando, Nuria Romero-Laorden, & Carlos Jara. (2010). Knowledge of hereditary renal cancer syndromes. Anti-Cancer Drugs. 22(Supplement 1). S15–S20. 4 indexed citations
14.
Leskelä, Susanna, Carlos Jara, Luis J. Leandro‐García, et al.. (2010). Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. The Pharmacogenomics Journal. 11(2). 121–129. 108 indexed citations
15.
Heras, Manuel, et al.. (2008). [Sepsis induced by Hafnia alvei in a kidney transplant patient].. PubMed. 28(4). 470–1. 5 indexed citations
16.
García‐Martínez, Jesús, María Dolores Folgueira, Rafaël Delgado, et al.. (2007). Viral monitoring and successful treatment of a ganciclovir‐resistant cytomegalovirus infection in a heart transplant recipient. Transplant Infectious Disease. 10(2). 123–128. 2 indexed citations
17.
Díaz‐Pedroche, Carmen, Carlos Lumbreras, Rafael San Juan, et al.. (2006). Valganciclovir Preemptive Therapy for the Prevention of Cytomegalovirus Disease in High-Risk Seropositive Solid-Organ Transplant Recipients. Transplantation. 82(1). 30–35. 37 indexed citations
18.
Hernando, Susana, María Dolores Folgueira, Carlos Lumbreras, et al.. (2005). Comparison of Cytomegalovirus Viral Load Measure by Real-Time PCR With pp65 Antigenemia for the Diagnosis of Cytomegalovirus Disease in Solid Organ Transplant Patients. Transplantation Proceedings. 37(9). 4094–4096. 26 indexed citations
19.
Hitt, Ricardo, María L. Amador, Miguel Quintela-Fandiño, et al.. (2005). Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Cancer. 106(1). 106–111. 34 indexed citations
20.
Jimeno, Antonio, Enrique González‐Billalabeitia, Susana Hernando, et al.. (2004). Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer. 100(11). 2462–2469. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sudhir Singh Breakdown of academic impact, for papers by Troy J. Plumb Breakdown of academic impact, for papers by Il Han Song Breakdown of academic impact, for papers by Rong Yao Breakdown of academic impact, for papers by Çağ Çal Breakdown of academic impact, for papers by R.W. Stockbrügger Breakdown of academic impact, for papers by Paolo Malvezzi Breakdown of academic impact, for papers by Thomas Shin Breakdown of academic impact, for papers by Helene Skjøt‐Arkil Breakdown of academic impact, for papers by Shipeng Yan
Rankless by CCL
2026